跳至主要内容
临床试验/RBR-10nnzgqh
RBR-10nnzgqh招募中3 期

Prophylaxis for Acute Pancreatitis after Endoscopic Retrograde Cholangiopancreatography (ERCP): clinical, randomized, double-blind trial to evaluate the efficacy of Diclofenac versus Indomethacin and the benefit in risk groups

Faculdade de Medicina de Sao Jose do Rio Preto0 个研究点开始时间: 2023年10月3日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Patients submitted to Endoscopic Retrograde Cholangiopancreatography; of both sexes; aged over 18 years

排除标准

  • Patients under 18 years of age; pregnant women; nursing mothers; those who do not accept or are not able to perform the Endoscopic Retrograde Cholangiopancreatography Exam(s) and follow-up during the study; Patients who lost clinical and laboratory follow-up due to hospital transfer or early death from severe cholangitis; patients with Non-steroidal anti-inflammatory drugs (NSAID) allergy and contraindication for use (i.e., active peptic ulcer, serum creatinine >1.4mg/dL, and single kidney) will also be excluded

研究者

相似试验